Quantcast
Home > Quotes > NTRA

Natera, Inc. Common Stock (NTRA) Quote & Summary Data

NTRA 
$15.95
*  
0.045
0.28%
Get NTRA Alerts
*Delayed - data as of Nov. 13, 2018  -  Find a broker to begin trading NTRA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
27.5
Today's High / Low
$ 16.63 / $ 15.80
Share Volume
451,443
50 Day Avg. Daily Volume
802,095
Previous Close
$ 15.905
52 Week High / Low
$ 29.62 / $ 8.60
Market Cap
983,684,350
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.59
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.91

Intraday Chart

Shares Traded

Share Volume:
451,443
50 Day Avg. Daily Volume:
802,095

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.59

Trading Range

The current last sale of $15.95 is 85.47% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 16.63 $ 29.62
 Low: $ 15.80 $ 8.60

Company Description (as filed with the SEC)

We are a growing diagnostics company with proprietary molecular and bioinformatics technology that we are deploying to change the management of genetic disease worldwide. Our novel molecular assays reliably measure many informative regions across the genome from samples as small as a single cell. Our statistical algorithms combine these measurements with data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with best-in-class accuracy and coverage. Our goal is to develop and commercialize non- or minimally-invasive tests to evaluate risk, and thereby enable early detection, for a wide range of genetic conditions, such as Down syndrome. Our technology has been proven clinically and commercially in the prenatal testing space.  ... More ...  


Risk Grade

Where does NTRA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 15.88
Open Date:
Nov. 13, 2018
Close Price:
$ 15.95
Close Date:
Nov. 13, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x